148 related articles for article (PubMed ID: 35127869)
21. Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study.
Narayan HK; Wei W; Feng Z; Lenihan D; Plappert T; Englefield V; Fisch M; Ky B
Open Heart; 2017; 4(1):e000524. PubMed ID: 28123764
[TBL] [Abstract][Full Text] [Related]
22. Myocardial Work Brings New Insights into Left Ventricular Remodelling in Cardio-Oncology Patients.
Vaz Ferreira V; Mano TB; Cardoso I; Coutinho Cruz M; Moura Branco L; Almeida-Morais L; Timóteo A; Galrinho A; Castelo A; Garcia Brás P; Simão D; Sardinha M; Gonçalves A; Cruz Ferreira R
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270517
[TBL] [Abstract][Full Text] [Related]
23. Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control Study.
Kosmala W; Negishi T; Thavendiranathan P; Penicka M; De Blois J; Murbræch K; Miyazaki S; Shirazi M; Santoro C; Vinereanu D; Cho GY; Hristova K; Popescu BA; Kurosawa K; Izumo M; Negishi K; Przewlocka-Kosmala M; Marwick TH
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207185
[TBL] [Abstract][Full Text] [Related]
24. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
[TBL] [Abstract][Full Text] [Related]
25. Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction.
Beer LA; Kossenkov AV; Liu Q; Luning Prak E; Domchek S; Speicher DW; Ky B
Circ Res; 2016 Oct; 119(10):1135-1144. PubMed ID: 27582370
[TBL] [Abstract][Full Text] [Related]
26. Impact of hypertension on left ventricular function in patients after anthracycline chemotherapy for malignant lymphoma.
Tanaka Y; Tanaka H; Hatazawa K; Yamashita K; Sumimoto K; Shono A; Suzuki M; Yokota S; Suto M; Mukai J; Takada H; Matsumoto K; Minami H; Hirata KI
Int J Cardiol; 2021 Jan; 323():126-132. PubMed ID: 32800904
[TBL] [Abstract][Full Text] [Related]
27. Echocardiography and cancer therapeutics-related cardiac dysfunction.
Tanaka H
J Med Ultrason (2001); 2019 Jul; 46(3):309-316. PubMed ID: 31030300
[TBL] [Abstract][Full Text] [Related]
28. Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction.
Xiao H; Wang X; Li S; Liu Y; Cui Y; Deng X
Front Cardiovasc Med; 2021; 8():753313. PubMed ID: 34859069
[TBL] [Abstract][Full Text] [Related]
29. [The predictive value of dynamic changes of coagulation function for the occurrence and progression of isolated distal deep vein thrombosis of lower limbs in patients with acute brain injury].
Tang R; Gao Z; Du M; Liu H; Yang Y; Ji Z; Zhou M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):721-726. PubMed ID: 34296693
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography.
Guan J; Bao W; Xu Y; Yang W; Li M; Xu M; Zhang Y; Zhang M
Front Pharmacol; 2021; 12():770580. PubMed ID: 34858189
[TBL] [Abstract][Full Text] [Related]
31. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
[TBL] [Abstract][Full Text] [Related]
32. Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study.
Rosenfeld R; Riondino S; Cerocchi M; Luciano A; Idone G; Lecis D; Illuminato F; Tolomei A; Torino F; Chiocchi M; Roselli M
Breast; 2024 May; 76():103755. PubMed ID: 38852211
[TBL] [Abstract][Full Text] [Related]
33. Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.
Finkelman BS; Putt M; Wang T; Wang L; Narayan H; Domchek S; DeMichele A; Fox K; Matro J; Shah P; Clark A; Bradbury A; Narayan V; Carver JR; Tang WHW; Ky B
J Am Coll Cardiol; 2017 Jul; 70(2):152-162. PubMed ID: 28683962
[TBL] [Abstract][Full Text] [Related]
34. Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction.
Santoro C; Esposito R; Lembo M; Sorrentino R; De Santo I; Luciano F; Casciano O; Giuliano M; De Placido S; Trimarco B; Lancellotti P; Arpino G; Galderisi M
Eur Heart J Cardiovasc Imaging; 2019 Dec; 20(12):1345-1352. PubMed ID: 31326981
[TBL] [Abstract][Full Text] [Related]
35. Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy.
Oikawa M; Yoshihisa A; Yokokawa T; Misaka T; Yaegashi D; Miyata M; Nakazato K; Ishida T; Takeishi Y
Oncology; 2020; 98(9):653-660. PubMed ID: 32454480
[TBL] [Abstract][Full Text] [Related]
36. Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy?: Impact of Temporal and Observer Variability.
Altaha MA; Nolan M; Marwick TH; Somerset E; Houbois C; Amir E; Yip P; Connelly KA; Michalowska M; Sussman MS; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2020 Apr; 13(4):951-962. PubMed ID: 31864977
[TBL] [Abstract][Full Text] [Related]
37. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of Integrating Heart Failure Risk Factors Into Impairment of Global Longitudinal Strain to Predict Anthracycline-Related Cardiac Dysfunction.
Milks MW; Velez MR; Mehta N; Ishola A; Van Houten T; Yildiz VO; Reinbolt R; Lustberg M; Smith SA; Orsinelli DA
Am J Cardiol; 2018 Apr; 121(7):867-873. PubMed ID: 29454478
[TBL] [Abstract][Full Text] [Related]
39. Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation.
Peleg Hasson S; Arnold J; Merdler I; Sivan A; Shamai S; Geva R; Merimsky O; Shachar E; Waissengrin B; Moshkovits Y; Arbel Y; Topilsky Y; Rozenbaum Z; Wolf I; Laufer-Perl M
J Immunother; 2021 Jun; 44(5):179-184. PubMed ID: 33950028
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer.
Bergamini C; Benfari G; Dolci G; Torelli F; Ghiselli L; Trevisani L; Truong S; Vinco G; La Russa F; Golia G; Molino A; Rossi A; Ribichini FL
Am J Cardiol; 2018 Sep; 122(5):885-889. PubMed ID: 30053998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
